{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:25:41Z","timestamp":1779236741274,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T00:00:00Z","timestamp":1438473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T00:00:00Z","timestamp":1438473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1002\/pds.3845","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T03:47:53Z","timestamp":1438573673000},"page":"1058-1067","source":"Crossref","is-referenced-by-count":12,"title":["Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation"],"prefix":"10.1002","volume":"24","author":[{"given":"Steven M.","family":"Brunelli","sequence":"first","affiliation":[{"name":"DaVita Clinical Research; Minneapolis MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Dluzniewski","sequence":"additional","affiliation":[{"name":"Amgen Inc.; Thousand Oaks CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry","family":"Cooper","sequence":"additional","affiliation":[{"name":"Amgen Inc.; Thousand Oaks CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thy P.","family":"Do","sequence":"additional","affiliation":[{"name":"Amgen Inc.; Thousand Oaks CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Sibbel","sequence":"additional","affiliation":[{"name":"DaVita Clinical Research; Minneapolis MN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Bradbury","sequence":"additional","affiliation":[{"name":"Amgen Inc.; Thousand Oaks CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,8,2]]},"reference":[{"issue":"suppl 3","key":"10.1002\/pds.3845-BIB0001|pds3845-cit-0001","first-page":"S1","article-title":"KDOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1002\/pds.3845-BIB0002|pds3845-cit-0002","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1002\/pds.3845-BIB0003|pds3845-cit-0003","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/pds.3845-BIB0004|pds3845-cit-0004","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1002\/pds.3845-BIB0005|pds3845-cit-0005","unstructured":"Sensipar [package insert] 2013"},{"issue":"suppl 1","key":"10.1002\/pds.3845-BIB0006|pds3845-cit-0006","first-page":"i7","article-title":"The role of the calcium-sensing receptor in the pathophysiology of secondary hyperparathyroidism","volume":"1","author":"Riccardi","year":"2008","journal-title":"NDT Plus"},{"issue":"suppl 1","key":"10.1002\/pds.3845-BIB0007|pds3845-cit-0007","first-page":"i36","article-title":"Potential future uses of calcimimetics in patients with chronic kidney disease","volume":"1","author":"Chonchol","year":"2008","journal-title":"NDT Plus"},{"key":"10.1002\/pds.3845-BIB0008|pds3845-cit-0008","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/pds.3845-BIB0009|pds3845-cit-0009","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3845-BIB0010|pds3845-cit-0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1542-4758.2011.00642.x","article-title":"Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols","volume":"16","author":"Chertow","year":"2012","journal-title":"Hemodial Int"},{"key":"10.1002\/pds.3845-BIB0011|pds3845-cit-0011","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1002\/pds.3845-BIB0012|pds3845-cit-0012","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.jrn.2006.04.010","article-title":"Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease","volume":"16","author":"Torres","year":"2006","journal-title":"J Ren Nutr"},{"key":"10.1002\/pds.3845-BIB0013|pds3845-cit-0013","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/ndt\/gfp144","article-title":"Cinacalcet and achievement of the NKF\/K-DOQI recommended target values for bone and mineral metabolism in real-world clinical practice-the ECHO observational study","volume":"24","author":"Urena","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1002\/pds.3845-BIB0014|pds3845-cit-0014","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1002\/pds.3845-BIB0015|pds3845-cit-0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/pds.3845-BIB0016|pds3845-cit-0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05241008","article-title":"Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006","volume":"4","author":"St Peter","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1002\/pds.3845-BIB0017|pds3845-cit-0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000350213","article-title":"Evaluating real-world use of cinacalcet and biochemical response to therapy in US hemodialysis patients","volume":"37","author":"Kilpatrick","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.1002\/pds.3845-BIB0018|pds3845-cit-0018","unstructured":"ClinicalTrials.gov. 20070360 Incident Dialysis https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00803712"},{"key":"10.1002\/pds.3845-BIB0019|pds3845-cit-0019","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/ndt\/15.11.1841","article-title":"Albumin-corrected calcium and ionized calcium in stable haemodialysis patients","volume":"15","author":"Clase","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1002\/pds.3845-BIB0020|pds3845-cit-0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1002\/pds.3845-BIB0021|pds3845-cit-0021","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1002\/pds.3845-BIB0022|pds3845-cit-0022","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-9343(88)90100-3","article-title":"Hungry bone syndrome: clinical and biochemical predictors of its occurrence after parathyroid surgery","volume":"84","author":"Brasier","year":"1988","journal-title":"Am J Med"},{"key":"10.1002\/pds.3845-BIB0023|pds3845-cit-0023","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/IJNRD.S56995","article-title":"Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients","volume":"7","author":"Florescu","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1002\/pds.3845-BIB0024|pds3845-cit-0024","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0272-6386(97)90131-1","article-title":"Biochemical aberrations in a dialysis patient following parathyroidectomy","volume":"29","author":"Cruz","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1002\/pds.3845-BIB0025|pds3845-cit-0025","doi-asserted-by":"crossref","first-page":"c80","DOI":"10.1159\/000151722","article-title":"Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism","volume":"110","author":"Viaene","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1002\/pds.3845-BIB0026|pds3845-cit-0026","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000156717","article-title":"Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"29","author":"Shigematsu","year":"2009","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1002\/pds.3845-BIB0027|pds3845-cit-0027","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.11721111","article-title":"Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol","volume":"7","author":"Isakova","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3845","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3845","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3845\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T23:02:57Z","timestamp":1625353377000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3845"}},"subtitle":["Low Calcium Among Dialysis Patients"],"short-title":[],"issued":{"date-parts":[[2015,8,2]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3845","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"value":"1053-8569","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,2]]}}}